Working… Menu

Changes in Body Composition Under Ustekinumab in PsA (STELARA-CC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03823924
Recruitment Status : Recruiting
First Posted : January 31, 2019
Last Update Posted : August 26, 2020
Janssen Pharmaceuticals
Information provided by (Responsible Party):
University Hospital, Lille

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 2022
Estimated Study Completion Date : July 2022